CD4 and rheumatoid arthritis: In rheumatoid arthritis, CD4+ T-cells infiltrate the degenerating rheumatoid synovium and produce cytokines—the T-cell blocker abatacept partially inhibits inflammatory disease progression among rheumatoid arthritis patients (von et al., 2012).